Table 4. Atherosclerotic prevalence in leukemia/lymphoma, lung, colorectal, breast, uterus/cervix, prostate cancer patients and control group: fractures; patients ≥ 50 years old.

	Subgroup	Prevalence (%) Within Total Athero	Prevalence (%) of Athero Within Total Subgroup
Both	Leukemia/Lymphoma	4.44	12.57
	Lung	5.35	17.63
	Colorectal*	5.54	18.17
Female	Breast	5.57	9.79
	Uterus/Cervix	1.41	11.47
Male	Prostate	5.86	18.40
Out group	Fractures	9.54	27.40

Prevalence (%) within total athero = (# of patients with specific cancer and athero) / (total # of patients with athero) * 100. Prevalence (%) of athero within total subgroup = (# of patient with specific cancer and athero) / (total # of patients with specific cancer) * 100.

* The colorectal data from BIDMC produced a fatal error in the union set search and was, therefore, excluded.